Results 61 to 70 of about 16,398 (301)

Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig   +9 more
wiley   +1 more source

Republication de : Ictus amnésique [PDF]

open access: yesJournal Européen des Urgences et de Réanimation, 2019
Resume L’ictus amnesique idiopathique (IA) realise un syndrome amnesique aigu affectant exclusivement la memoire episodique anterograde et retrograde, durant moins de 24 heures et regressant sans sequelles. Il touche les personnes de plus de 50 ans et survient souvent apres un stress physique ou emotionnel. Il peut recidiver dans environ 10 % des cas.
Viader, F., Quinette, P., Cogez, J.
openaire   +3 more sources

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Código ictus [PDF]

open access: yes, 2018
El ictus es una emergencia neurológica. Los estudios y conocimientos que se tienen acerca del mismo han podido determinar que una vez que se produce la hemorragia o isquemia cerebral su progresión es muy rápida.
Neila Santucci, Sara
core  

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillation

open access: yesNeurology Perspectives
Introduction: Direct oral anticoagulants (DOACs) are the first line of stroke prevention treatment in patients with non-valvular atrial fibrillation (NVAF).
E.M. Bacas   +5 more
doaj   +1 more source

Evaluación de la revisión telefónica en la recurrencia de ictus y AIT

open access: yesNeurología, 2012
Resumen: Introducción: La recurrencia de ictus o AIT es un aspecto clave en la mayoría de los registros de ictus, pero la revisión presencial de todos los pacientes no siempre es viable.
F. Moniche   +5 more
doaj   +1 more source

Ictus Emeticus

open access: yesPediatric Neurology Briefs, 2004
A 9-year-old Arabic male with a 5 year history of recurrent episodes of severe vomiting and unusual frightened behavior, was eventually diagnosed with ictal vomiting, in a report from Schneider Childrens Medical Center of Israel, Petah Tiqva, and Sackler Faculty of Medicine, Tel Aviv University, Israel.
openaire   +4 more sources

Ictus : proceso asistencial integrado

open access: yes, 2015
Publicado en la página web de la Consejería de Igualdad, Salud y Políticas Sociales: www.juntadeandalucia.es/salud (Consejería de Salud / Profesionales / Nuestro Compromiso por la Calidad / Procesos Asistenciales Integrados)Numerosos grupos científicos ...
Sanz Amores, Reyes   +5 more
core  

Ictus criptogénico: ¿existe relación con cáncer oculto? [PDF]

open access: yes, 2023
[spa] La Organización Mundial de la Salud (OMS) clasifica las principales causas de defunción en el siguiente orden: la cardiopatía isquémica, el accidente cerebrovascular, la enfermedad pulmonar obstructiva y el cáncer. Además, la Sociedad Española de
Ortiz Ferrà, Marina
core  

Home - About - Disclaimer - Privacy